Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Medication access is determined solely by a licensed provider after clinical evaluation
In total, 9341 participants (6322 on previously or currently licensed weight management drugs and 3019 on non-drug therapies or placebo) were included
In the 64-week trial, adults taking 25 mg daily lost approximately 17% of their body weight if they stayed on treatment and 14% overall
He lost a little bit of weight with lifestyle changes, protein shakes and daily walks, but as soon as he began taking Ozempic, the weight melted off
Mounjaro (tirzepatide): Manufactured by Eli Lilly and FDA-approved for type 2 diabetes, Mounjaro targets both GLP-1 and GIP receptors and has been widely prescribed off-label for weight loss
Stopping Zepbound may lead to weight regain if lifestyle changes are not maintained
US$ 29.03
US$ 27.65
US$ 24.53
